Titlebook: Ischemia-reperfusion in cardiac surgery; Hans Michael Piper,Claus J. Preusse Book 1993 Kluwer Academic Publishers 1993 Bypass.cardiac func

采納

Magisterial

https://doi.org/10.1007/978-94-011-1713-5Bypass; cardiac function; cardiac surgery; cardiology; heart; physiology; thoracic surgery

Protein

Developments in Cardiovascular Medicinehttp://image.papertrans.cn/i/image/475532.jpg

FLORA

不規(guī)則

Cardioplegia with an extracellular formulationThe clinical use of cardioplegia is now accepted world-wide for all aspects of cardiac surgery. Myocardial protection can be achieved with a number of cardioplegic solutions but, essentially, there are only two types of solution — the ‘extracellular-type’ and the ‘intracellular-type’. The latter has been covered in the preceding chapter.

Muscularis

Retrograde perfusionically-induced ischemic arrest. More recently, the introduction of normothermic continuous blood cardioplegia has further contributed to expand the indications of the retrograde approach. The purpose of the present review is therefore to provide an update of the indications, techniques and pitfalls of coronary sinus cardioplegia.

Patrimony

啞巴

High-energy phosphates and their catabolitesfore, during and after cardiac surgery. We address the relationship between these compounds and cardiac function, e.g. during stunning. In addition we describe their role for cardioprotection, e.g. during cardioplegia.

squander

978-94-010-4750-0Kluwer Academic Publishers 1993

Insubordinate

Ischemia-reperfusion in cardiac surgery978-94-011-1713-5Series ISSN 0166-9842